Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

about

Foreword to 'Multiscale structural biology: biophysical principles and mechanisms underlying the action of bio-nanomachines', a special issue in Honour of Fumio Arisaka's 70th birthday.

P2860

Q52368723-D8CCE7D0-ED12-4D49-941C-91EE1F0E4E8D

P2860

Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

Item

http://www.wikidata.org/entity/Q52360303

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en-gb

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@nl

type

Item

label

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en-gb

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@nl

prefLabel

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en-gb

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@nl

P1476

Antimicrobial resistance (AMR) ...... n, efflux and/or deactivation.

@en

P2093

Stephen E Harding

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmid-mediated quinolone resistance: a multifaceted threat

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Structural basis of gate-DNA breakage and resealing by type II topoisomerases

Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion

Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme

A protein functional leap: how a single mutation reverses the function of the transcription regulator TetR

Crystal structures of the complexes between vancomycin and cell-wall precursor analogs

Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases

Type IIA topoisomerase inhibition by a new class of antibacterial agents

P2888

s12551-018-0404-9

P304

347-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12551-018-0404-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mary K Phillips-Jones

P577

2018-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29525835

http://www.w3.org/2001/XMLSchema#string

P921

antimicrobial resistance

P932

5899746

http://www.w3.org/2001/XMLSchema#string

Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

about

P2860

P2860

Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932